Health TrialsbyHealthPanel

Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth Intervention

ConditionOpioid Use Disorder
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania

About this trial

The goal of this pilot trial is to develop and test a telehealth intervention for OUD care delivery and refine measurement strategies.

The specific aims are to: 1) identify components of an effective telehealth intervention and barriers to implementation, 2) partner with an advisory board of OUD treatment stakeholders from different settings to develop a telehealth intervention for OUD treatment with buprenorphine, and 3) conduct a pilot trial of the telehealth intervention for OUD treatment.

The investigators will enroll 60 patients, 30 individuals who are currently enrolled in in-person OUD treatment with buprenorphine, with a treatment episode duration of 1-3 months, and 30 individuals who are not currently receiving OUD treatment but approved for treatment intake at buprenorphine clinic by an OUD treatment clinician, to receive the telehealth for OUD care delivery intervention. The investigators will measure clinical, implementation, and patient satisfaction outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Telehealth for opioid use disorder treatment delivery

    Behavioral

    A multi-component patient and provider facing strategy to be designed in Aim 2. Components will likely include 1) a user-friendly telehealth platform for performing all medication induction and maintenance visits, 2) integrated case management, 3) text message scheduling reminders, 4) mailed saliva drug screening tests

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: Patients with OUD, eligible for treatment with buprenorphineExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Treatment Engagement

Enrolled in care; attended scheduled follow up visits or has rescheduled missed visits with care team; has filled, active buprenorphine prescription (from self-report and EHR)

Time frame
14,30, 90 days

Secondary outcomes

1

Days of medication for OUD

Proportion of days with filled buprenorphine prescription (from self-report and EHR)

Time frame
14, 30, 90 days
2

Opioid and non-opioid substance use

Days of opioid and non-opioid substance use in past 7 days (from self-report and EHR)

Time frame
Substance use in past 7 days, measured at 14, 30, 90 days
3

Feasibility of intervention

Provider and patient view about telehealth intervention. These data will be collected qualitatively via one on one interviews

Time frame
30 and 90 days
4

Acceptability

Provider and patient view about telehealth intervention. These data will be collected qualitatively via one on one interviews.

Time frame
30 and 90 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Pennsylvania

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: